EP Patent

EP1695965A1 — Forme cristalline beta du chlorhydrate de l'ivabradine, son procédé de préparation, et les compositions pharmaceutiques qui la contiennent

Assigned to Les Laboratoires Servier SAS · Expires 2006-08-30 · 20y expired

What this patent protects

Forme cristalline β du chlorhydrate de l'ivabradine de formule (I) : caractérisée par son diagramme de diffraction X sur poudre. Médicaments.

USPTO Abstract

Forme cristalline β du chlorhydrate de l'ivabradine de formule (I) : caractérisée par son diagramme de diffraction X sur poudre. Médicaments.

Drugs covered by this patent

Patent Metadata

Patent number
EP1695965A1
Jurisdiction
EP
Classification
—
Expires
2006-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.